|
|
|
The Group Health Research Advisory Board
The Group Health Research Advisory Board is responsible for
assessing the quality, innovation, and relevance of Group Health
research in enhancing quality of care and consumer value within Group
Health and nationally. The Board is appointed by the President and
Chief Executive Officer of Group Health. It is staffed by the office
of Eric Larson, MD, director of Group Health Center for Health
Studies.
- Ruth Ballweg, MPA, chairs the group.
She is director of the MEDEX Northwest Physician Assistant
Program in the University of Washington's School of Medicine and
Chair of the Group Health Board of Trustees.
Members are:
- Mary L. ‘Nora’ Disis, MD, PhD,
Professor, Medicine/Oncology/Tumor Vaccine Group, Center for
Translational Medicine in Women’s Health, University of
Washington
- James Hereford, Vice President,
Strategic Services and Quality, Group Health Cooperative
- Pam MacEwan, Vice President, Public
Affairs and Governance, Group Health Cooperative
- David McCulloch, MD, Medical
Director, Clinical Improvement, Group Health Cooperative
- Mary McColl Neilson, active leader in
Group Health's Senior Caucus
- Ross Prentice, PhD, Principal
Investigator of the Women's Health Initiative Clinical
Coordinating Center, Fred Hutchinson Cancer Research Center
- Laura Rehrmann, President and Chief
Executive Officer of the Group Health Community Foundation
- Joe Selby, MD, Director of the
Division of Research, Kaiser Permanente Northern California
- John Slattery, PhD, Vice Dean,
Research & Graduate Education, School of Medicine and Professor,
Pharmacology and Medicine, University of Washington
- Hugh Straley, MD, Medical Director of
Group Health and President of Group Health Permanente
- Michael Wanderer, MD, a family
practitioner at Group Health's Capitol Hill Family Health Center
and a member of the Group Health Permanente Board of Directors
Top |
|
|
search
